Abstract:Cell death is attributed to the unrecoverable disturbance of cells exposed to intracellular or extracellular stimulus. Regulated cell death (RCD), also known as programmed cell death (PCD), involves signaling cascades in which effector molecules participate in and play important roles for maintaining organism homeostasis. As a basic biological phenomenon of cells, RCD displays exceptional influence on the occurrence and development of many pathophysiological processes. N6-methyladenosine (m6A) is an important epigenetic modification that regulates RNA fate and subsequent bioprocesses. It occurs extensively on multiple RNA species and is the most abundant internal modification of eukaryotic messenger RNA (mRNA). The abundance of m6A modification is regulated by its methyltransferases and demethylases, and the diverse biological functions of m6A are executed by distinct m6A binding proteins. Accruing evidence shows that m6A modification participates in eukaryotic cell fate transition and determination. In recent years, the disorder of m6A modification status has been observed during the initiation and progression of various RCDs, including classical apoptosis, necroptosis, pyroptosis, and the newly described ferroptosis. Due to the importance of m6A and RCD in cellular and organismal homeostasis, it is worthwhile to recapitulate and organize the current knowledge of the crosstalk between m6A status and RCDs with distinct biochemical and morphological features, as well as immune consequences. In this chapter, we systematically summarize the regulatory networks of m6A modification on RCDs to provide the profiling of m6A-RCD regulatory axis as comprehensively as possible.

The Roles of RNA N6-Methyladenosine in Regulating Stem Cell Fate

The emerging roles of N6-methyladenosine RNA methylation in human cancers

Rna N-6-Methyladenosine Methylation In Post-Transcriptional Gene Expression Regulation

RNA N6-Methyladenine Modification, Cellular Reprogramming, and Cancer Stemness

Epitranscriptomic M6a Modification in the Stem Cell Field and Its Effects on Cell Death and Survival.

The Roles of M6a RNA Modifiers in Human Cancer

N6-methyladenosine Modification: an Important Player in the Tumor Immune Microenvironment.

The roles of m<SUP>6</SUP>A RNA modifiers in human cancer

The regulatory role of m 6 A modification in the maintenance and differentiation of embryonic stem cells

M(6)a RNA Modification Controls Cell Fate Transition in Mammalian Embryonic Stem Cells.

N 6 ‐methyladenosine Steers RNA Metabolism and Regulation in Cancer

The Emerging Molecular Mechanism of M6a Modulators in Tumorigenesis and Cancer Progression

Role of N6-methyladenosine RNA modification in cancer

Biological Roles of the RNA M6a Modification and Its Implications in Cancer

N6-methyladenosine (m6a) RNA Modification in Cancer Stem Cells

Multifaceted Functions of RNA m6A Modification in Modulating Regulated Cell Death

N6-methyladenosine (m6A)RNAmodification in cancer stem cells

The N6-Methyladenosine RNA modification in pluripotency and reprogramming

N6-methyladenosine (m6a) As a Regulator of Carcinogenesis and Drug Resistance by Targeting Epithelial-Mesenchymal Transition and Cancer Stem Cells

The role of m6A modification in the biological functions and diseases

The potential role of RNA N6-methyladenosine in Cancer progression